Back to Trades
STOLPER MARK
DirectorCIK 0001281961
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Across 6 filings between 2025–2026, STOLPER MARK, Director, has disclosed $3.0M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $2.6M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jul 29 | TOI Oncology Institute, Inc. | STOLPER MARK | Director | Grant | $0 |
| Jul 9 | TOI Oncology Institute, Inc. | STOLPER MARK | Director | Grant | $0 |
| Mar 5 | RDNT RadNet, Inc. | STOLPER MARK | EVP, Chief Financial Officer | Grant | $0 |
| Jan 12 | TOI Oncology Institute, Inc. | STOLPER MARK | Director | Other | $0 |
| Dec 12 | RDNT RadNet, Inc. | STOLPER MARK | EVP, Chief Financial Officer | Exercise | $433.4K |
| Sep 18 | RDNT RadNet, Inc. | STOLPER MARK | EVP, Chief Financial Officer | Sell | $2.6M |
6 filings